News Releases Year: All News20182017201620152014 Items per page All News2550 Summary ToggleContraVir Reports Key CMX157 Data at HEP DART 2015 Demonstrating Enhanced in vitro Safety Profile Compared to Viread® Summary Toggle December 8, 2015 View News Release > Summary ToggleContraVir Strengthens Board of Directors with Addition of Industry Veteran Arnold Lippa, Ph.D. Summary Toggle December 3, 2015 View News Release > Summary ToggleContraVir to Present New CMX157 Data at HEP DART 2015 Summary Toggle December 1, 2015 View News Release > Summary ToggleContraVir to Present at the Salomon Bio Investment & Leadership Conference Summary Toggle November 10, 2015 View News Release > Summary ToggleContraVir to Present at the 14th Annual BIO Investor Forum Summary Toggle October 14, 2015 View News Release > Summary ToggleContraVir Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock And Warrants Summary Toggle October 13, 2015 View News Release > Summary ToggleContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock Summary Toggle October 7, 2015 View News Release > Summary ToggleContraVir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock Summary Toggle October 6, 2015 View News Release > Summary ToggleContraVir Reports New Data demonstrating CMX157 to be 60-Fold More Potent Against Hepatitis B Virus than Gilead's Viread® Summary Toggle October 5, 2015 View News Release > Summary ToggleContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference Summary Toggle September 1, 2015 View News Release > Pagination Current page 1 Page 2 Page 3 Next page Next Last page Last
